Efficacy of Topical Ivermectin Weekly for 12 Weeks in Pediculosis Capitis
Chinese Journal of Cancer Prevention and Treatment · 17.07.2026 · 33 (7) · 8-13
DOI: 10.61336/cjpt/26-7-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chinese Journal of Cancer Prevention and Treatment, online erschienen am 17.07.2026.
Abstract (Originalsprache)
Chronic, heavy infestation with head lice (Pediculus humanus capitis) can rarely cause anaemia, particularly in rural females who already have iron-deficiency anaemia. A single treatment with topical ivermectin (IVM) may produce an earlier response and higher cure rate than oral IVM.
Objective
To determine the efficacy of weekly topical ivermectin (2% concentration) given for 12 weeks in patients with pediculosis capitis.
Methods
This prospective clinical study was conducted in the Department of Dermatology, Abbasi Shaheed Hospital, Karachi, from 17 May to 16 November 2019. A total of 194 patients meeting the inclusion criteria were enrolled by non-probability consecutive sampling. All subjects were treated with 2% topical ivermectin applied to the scalp and hair, left in place for 10 minutes, and rinsed. Infestation and pruritus severity were scored at baseline and at 12 weeks. Efficacy was defined as the absence of live lice at the 12-week assessment. Data were analysed in SPSS v21; results were stratified by age, gender, body mass index (BMI), hair length, hair texture, and hair curliness, with post-stratification chi-square testing (p ≤ 0.05 considered significant).
Results
Of 194 patients, 20.1% were male and 79.9% were female (mean age 27.15 ± 8.78 years). Mean infestation and pruritus scores fell from 1.46 ± 0.74 and 1.65 ± 0.65 at baseline to 0.29 ± 0.52 and 0.31 ± 0.50 at 12 weeks, respectively. At 12 weeks, 73.2% of patients had no infestation and 70.6% had no pruritus. Overall treatment efficacy was 60.3%. Efficacy was significantly associated with male gender (84.6% vs 54.2% in females, p = 0.001) and shorter hair length (≤35 cm: 67.0% vs >35 cm: 53.2%, p = 0.049); no significant association was found with age, BMI, hair texture, or hair curliness.
Conclusion
Weekly topical ivermectin (2%) for 12 weeks demonstrated high efficacy in pediculosis capitis, producing significantly higher cure of infestation and faster relief of pruritus, with male sex and shorter hair length as favourable prognostic factors
Zitieren
APA
(2026). Efficacy of Topical Ivermectin Weekly for 12 Weeks in Pediculosis Capitis. Chinese Journal of Cancer Prevention and Treatment, 33(7), 8-13. https://doi.org/10.61336/cjpt/26-7-2
Vancouver
Efficacy of Topical Ivermectin Weekly for 12 Weeks in Pediculosis Capitis. Chinese Journal of Cancer Prevention and Treatment. 2026;33(7):8-13. doi:10.61336/cjpt/26-7-2
BibTeX
@article{euvimed2026,
title = {Efficacy of Topical Ivermectin Weekly for 12 Weeks in Pediculosis Capitis},
journal = {Chinese Journal of Cancer Prevention and Treatment},
year = {2026},
volume = {33},
number = {7},
pages = {8--13},
doi = {10.61336/cjpt/26-7-2}
}
EUVIMED